ANN LILLIS: Open Payments
NPI 1609852607 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,299 in 234 payments from 23 companies in 2025. Trend: 2023 $2,896 · 2024 $4,049 · 2025 $4,299
Food & beverage: $4,288Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 92 | $1,272 |
| ABBVIE INC. | 30 | $705 |
| Lilly USA, LLC | 20 | $395 |
| PFIZER INC. | 26 | $346 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $274 |
| Phathom Pharmaceuticals, Inc. | 5 | $236 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $180 |
| Ardelyx, Inc. | 6 | $151 |
| QOL Medical, LLC | 4 | $136 |
| Madrigal Pharmaceuticals | 4 | $105 |
Products named: TREMFYA, OMVOH, VELSIPITY, SKYRIZI, VOQUEZNA, ENTYVIO, RINVOQ, XIFAXAN.
Industry payments across NY — which companies pay providers there.
